Cas:885275-71-8 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-2-pyridin-4-ylacetic acid manufacturer & supplier

Chemical Name:2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-2-pyridin-4-ylacetic acid

CAS.NO:885275-71-8

Synonyms:1H-1,4-Diazepine-1-aceticacid,4-[(1,1-dimethylethoxy)carbonyl]hexahydro-a-4-pyridinyl;1-boc-4-(carboxypyridin-4-yl-methyl)-[1,4]diazepane

Molecular Formula:C₁₇H₂₅N₃O₄

Molecular Weight:335.39800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:82.97000

Exact Mass:335.18500

LogP:2.02590

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1H-1,4-Diazepine-1-aceticacid,4-[(1,1-dimethylethoxy)carbonyl]hexahydro-a-4-pyridinyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-boc-4-(carboxypyridin-4-yl-methyl)-[1,4]diazepane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-1,4-Diazepine-1-aceticacid,4-[(1,1-dimethylethoxy)carbonyl]hexahydro-a-4-pyridinyl Use and application,1-boc-4-(carboxypyridin-4-yl-methyl)-[1,4]diazepane technical grade,usp/ep/jp grade.

Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-2-pyridin-4-ylacetic acid manufacturer The measure starts on February 4, according to South Korean Prime Minister Chung Sye-kyun. 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-2-pyridin-4-ylacetic acid supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-2-pyridin-4-ylacetic acid vendor Further research on Oligomannate��s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement. 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-2-pyridin-4-ylacetic acid factory In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.